A 2023 study by Zapata-Cobo et al. found an association between the homozygous variant of the rs2241880 G allele in gen ATG16L1 and long-term non-response in pediatric patients with IBD treated with ADA. This evidence concerns the gene ATG16L1 and inflammatory bowel disease.